hexintong

Hexintong is a Traditional Chinese Medicine (TCM) formulation, typically administered as an oral liquid, used for the treatment of cardiovascular conditions and dyslipidemia. Developed or utilized by the Liaoning Provincial Health Industry Group Ben'gang General Hospital, it is often studied as an adjunctive therapy to standard treatments like rosuvastatin. Clinical research, such as trial ChiCTR2200057751, has focused on its ability to reduce elevated lipoprotein (a) [Lp(a)] levels, a known risk factor for cardiovascular disease that is often resistant to conventional statin therapy. As a botanical-based product, its therapeutic profile is derived from a combination of herbal extracts intended to improve blood flow and metabolic health.

Brand names

Hexintong

Other names

Hexintong oral liquidcardiac oral solutionHe Xin Tong